JAAHA Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dyson, D.
Right arrow Articles by Schnurr, D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dyson, D.
Right arrow Articles by Schnurr, D
Journal of the American Animal Hospital Association, Vol 34, Issue 4, 325-335
Copyright © 1998 by American Animal Hospital Association


Articles

Morbidity and mortality associated with anesthetic management in small animal veterinary practice in Ontario

DH Dyson, MG Maxie, and D Schnurr

During 1993, 66 small animal practices participated in a prospective study to evaluate the incidence and details of anesthetic-related morbidity and mortality. Considering a total of 8,087 dogs and 8,702 cats undergoing anesthesia, the incidences of complications were 2.1% and 1.3%, respectively. Death occurred in 0.11% and 0.1% of cases, respectively. Logistic regression models were developed and showed that a significant odds ratio (OR) of complications in dogs was associated with xylazine (OR, 91.5); heart rate monitoring (OR, 3.2); American Society of Anesthesiologists (ASA) 3, 4, or 5 classification (OR, 2.5); isoflurane (OR, 2.4); butorphanol (OR, 0.35); technician presence (OR, 0.26); acepromazine (OR, 0.24); ketamine (OR, 0.21); and mask induction (OR, 0.2). Complications in cats were associated with ASA 3, 4, or 5 classification (OR, 5.3); diazepam (OR, 4.1); intubation (OR, 1.7); butorphanol (OR, 0.45); and ketamine (OR, 0.17). Cardiac arrest in dogs was associated with xylazine (OR, 43.6) and ASA 3, 4, or 5 classification (OR, 7.1). Cardiac arrest in cats was associated with ASA 3, 4, or 5 classification (OR, 21.6) and technician presence (OR, 0.19). This paper reports the incidences of complications and cardiac arrest in small animal practice and identifies common complications and factors that may influence anesthetic morbidity and mortality. This information may be useful in comparing anesthetic management practices.


This article has been cited by other articles:


Home page
Vet Rec.Home page
R. K. Alvaides, F. J. T. Neto, A. J. A. Aguiar, D. Campagnol, and P. V. M. Steagall
Sedative and cardiorespiratory effects of acepromazine or atropine given before dexmedetomidine in dogs
Vet Rec., June 28, 2008; 162(26): 852 - 856.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
D. C. Brodbelt, D. U. Pfeiffer, L. E. Young, and J. L. N. Wood
Risk factors for anaesthetic-related death in cats: results from the confidential enquiry into perioperative small animal fatalities (CEPSAF)
Br. J. Anaesth., November 1, 2007; 99(5): 617 - 623.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Animal Hospital Association.